Literature DB >> 949171

Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis.

I Phillips, C Warren.   

Abstract

Minimum inhibitory concentrations (MICs) of sulfamethoxazole (SMX) and trimethoprim (TMP), alone and in three combinations, 20:1, 1:1, and 1:20, were determined on Diagnostic Sensitivity Test (DST) and Mueller-Hinton (MH) agars containing lysed blood for various inocula of 91 strains of Bacteroides fragilis from the U.S.A. and U.K. MICs of SMX were high with large inocula and higher on MH than DST, but results for TMP were less affected by these two factors. True SMX resistance was rare: 10 U.S.A. strains previously reported as resistant appeared to be susceptible. Maximum potentiation of MICs was observed when SMX and TMP were combined in ratios close to those of the ratios of their MICs, that is, SMX/TMP 20:1 for large inocula and the reverse for small inocula for determinations on DST and usually 20:1 for all inoculum sizes on MH. These observations explain some of the discrepancies in reports, but defer the problem of potential usefulness of the drugs in the treatment of infection with anaerobes to future study.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 949171      PMCID: PMC429613          DOI: 10.1128/AAC.9.5.736

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites.

Authors:  G B ELION; S SINGER; G H HITCHINGS
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157

2.  Susceptibility of Bacteroides fragilis to trimethoprim and sulphamethoxazole.

Authors:  I Phillips; C Warren
Journal:  Lancet       Date:  1974-05-04       Impact factor: 79.321

3.  Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.

Authors:  J E Rosenblatt; P R Stewart
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

  3 in total
  10 in total

1.  Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases.

Authors:  R L Then; P Angehrn
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

2.  Activity of brodimoprim and metioprim alone and in combination with sulfonamides against anaerobic bacteria.

Authors:  J Wüst; J Schwarzenbach
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

3.  Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing.

Authors:  J Wüst; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

4.  In vitro susceptibility of anaerobes to co-trimoxazole.

Authors:  J Wüst
Journal:  Infection       Date:  1980       Impact factor: 3.553

5.  Metronidazole and anaerobic sepsis.

Authors:  S J Eykyn; I Phillips
Journal:  Br Med J       Date:  1976-12-11

6.  Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistance.

Authors:  Kathleen M Frey; Kishore Viswanathan; Dennis L Wright; Amy C Anderson
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

7.  Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.

Authors:  R L Guerrant; S J Wood; L Krongaard; R A Reid; R H Hodge
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

8.  Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.

Authors:  E B Fraser-Smith; T R Matthews
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella.

Authors:  E J Perea; M A Torres; M V Borobio
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

10.  Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents.

Authors:  P F Dougherty; D W Yotter; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.